Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake

• Andrew Fesler,
• Ga-Ram Hwang,
• Jingfang Ju

Affiliations

Andrew Fesler

Curamir Therapeutics Inc., Woburn, MA 01801, USA

Ga-Ram Hwang

Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA

Jingfang Ju

Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; The Northport Veteran's Administration Medical Center, Northport, NY 11768, USA; Corresponding author. Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA. Fax: +1 (631) 444 3330.